Synopsis:
Alpex Solar secured a Rs. 230 crore solar module order from a leading industry player, scheduled for completion by March 2026.
During Wednesday’s trading session, shares of a company manufacturing photovoltaic modules and providing all-inclusive solar energy solutions surged nearly 11 percent to hit a record high at Rs. 1,260 on NSE, after securing an order worth Rs. 230 crores for the supply of solar modules.
At 11:08 a.m., shares of Alpex Solar Limited were trading in the green at Rs. 1,226.95 on NSE, up by nearly 8.2 percent, as against its previous closing price of Rs. 1,133.8, with a market cap of Rs. 2,988 crores.
What’s the News
As per the latest regulatory filings with the NSE, Alpex Solar Limited has secured a commercial order worth Rs. 230 crores from a Leading Industry Player for the supply of solar modules. The order is scheduled to be completed by March 2026.
Previously, on 15th July, the company received approval of a definitive procurement arrangement for solar cells with a minimum aggregate capacity of 300 megawatts (MW) from TP Solar Limited.
This strategic tie-up ensures long-term supply stability, supports manufacturing expansion, and boosts production capacity. It strengthens dispatch readiness for key clients, including SECI, CMPDI (a Subsidiary of Coal India Ltd.), NTPC, and SCCL.
Financials & more
Alpex Solar reported a significant growth in its revenue from operations, showing a year-on-year rise of around 170 percent from Rs. 121 crores in Q4 FY24 to Rs. 327 crores in Q4 FY25. Similarly, its net profit increased during the same period from Rs. 6 crores to Rs. 35 crores, representing an impressive rise of about 483 percent YoY.
Alpex Solar Limited is primarily engaged in the business of manufacturing solar modules and assembling solar pumps in India. In FY25, the company generated 83.4 percent of total revenues from manufacturing solar PV modules.
Written by Shivani Singh
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
